Mesenchymal Stem Cells for The Treatment of Acute Ischemic Stroke
Clinical trial NCT04097652 · UNKNOWN
Trial details
- NCT number
- NCT04097652
- Sponsor
- Meridigen Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-12-05
- Primary completion
- 2023-12-31
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.